Novozymes Biopharma announces collaboration with Almac

Novozymes Biopharma is delighted to announce its new collaboration with Almac, to provide a combined service for drug development...

Sintered porous materials for medical applications

Porvair Filtration Group will be exhibiting at the Medica / CompaMed 2013 trade show in Düsseldorf.

Redipor success drives Cherwell cleanroom expansion

Cherwell Laboratories, leading supplier of microbiology media and instruments for pharmaceutical and related industries, is continuing with...

PETA International Science Consortium

For more than a decade, PETA US has been the scientific leader among animal-protection organisations worldwide. Now, in a landmark move,...

Cherwell highlights products for environmental monitoring and process validation

Cherwell Laboratories, experts in environmental monitoring and process validation will be demonstrating their comprehensive product range at...

Novartis receives EU approval for Ilaris®

Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis

Energy efficient freeze drying enhances pharmaceutical production

SP Scientific has produced a new technical brief that summarises the energy saving features available on its Hull range of production freeze...

World’s pharmaceutical development manufacturing base moving to India

The India Brand Equity Foundation (IBEF) has compiled its findings and released an overview of the current generics market in India.

China’s ‘Five Year Plan’ underway as attendance at 2013 show rockets

The ‘Five-Year Plan’, implemented by the Chinese government targets pharmaceutical R&D as a key initiative, with financial and...

Trophos completes patient enrolment in a first study of olesoxime in relapsing remitting Multiple Sclerosis

Topline results for olesoxime as add–on therapy to Interferon beta are expected in early 2014

CPhI Pharma Insights: formulation and ingredients report

CPhI Worldwide and CPhI Pharma Evolution announce the conclusions of its first monthly report into the current status of the formulation and...

Alize Pharma launches the first Phase I clinical trial for AZP-531

The Medicine and Healthcare Regulatory Authority (MHRA) has granted authorization to conduct a trial in the UK on AZP-531 in healthy...

Routine generation of powder samples from HPLC fractions

Genevac reports that its HT Series II Evaporator using the Fast Lyophilisation, or LyoSpeed™ process is enabling a growing number of...

Tetrahedron announces Selisseo(R) market authorization

Selisseo is an innovative nutritional supplement stemming from Tetrahedron R&D and developed under license by Adisseo.

“E” reshaping Marketing – Are you ready, Pharma?

Fleming Europe is organizing its 3rd Annual Pharma eMarketing Congress, this time with the aim to provide a platform for exchange of...

Roche’s Avastin approved in Japan

First approval of Avastin for the treatment of newly diagnosed glioblastoma in combination with radiotherapy and temozolomide chemotherapy

Almac announces further expansion and new jobs

Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Over the next three years up to 229 jobs...

Cherwell supports pharmig disinfectant implementation seminar

Cherwell Laboratories will be exhibiting their range of specialist products for environmental monitoring and process validation at...

Asian Patient Access Leaders Forum

NextLevel Pharma’s Asian Patient Access Leaders Forum is the must-attend event for all Market Access, Pricing, HEOR, Government Relations...

Novozymes Biopharma’s recombinant human albumin helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, has announced that an ophthalmic solution made using its...




To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited